Cellular Uptake of Psychostimulants – Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular Uptake of Psychostimulants – Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-20
DOI
10.3389/fphar.2020.609811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Designer drugs: mechanism of action and adverse effects
- (2020) Dino Luethi et al. ARCHIVES OF TOXICOLOGY
- Bioactive compounds and health benefits of Pereskioideae and Cactoideae: A review
- (2020) Tânia da Silveira Agostini-Costa FOOD CHEMISTRY
- The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective
- (2019) Tai Rao et al. PHARMACOLOGICAL RESEARCH
- Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1
- (2019) Marleen J. Meyer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A
- (2019) Muhammad Rafehi et al. Frontiers in Pharmacology
- Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters
- (2019) Ole Jensen et al. BIOCHEMICAL PHARMACOLOGY
- Organic Cation Transporters in Health and Disease
- (2019) Hermann Koepsell PHARMACOLOGICAL REVIEWS
- Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium
- (2018) Sook Wah Yee et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- OCT1 deficiency affects hepatocellular concentrations and pharmacokinetics of cycloguanil, the active metabolite of the antimalarial drug proguanil
- (2018) Johannes Matthaei et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association between cytochrome P450 2D6 polymorphisms and body fluid methamphetamine concentrations in Japanese forensic autopsy cases
- (2018) Aya Matsusue et al. FORENSIC SCIENCE INTERNATIONAL
- An unsuspected role for organic cation transporter 3 in the actions of amphetamine
- (2018) Felix P. Mayer et al. NEUROPSYCHOPHARMACOLOGY
- “Polytox” synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux
- (2018) Felix P. Mayer et al. NEUROCHEMISTRY INTERNATIONAL
- N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
- (2018) Steven A. Barker Frontiers in Neuroscience
- Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects
- (2018) Patrick Vizeli et al. ACS Chemical Neuroscience
- Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
- (2018) Matthew W. Johnson et al. PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic And Pharmacodynamic Aspects Of Peyote And Mescaline: Clinical And Forensic Repercussions
- (2018) Ricardo Jorge Dinis-Oliveira et al. Current Molecular Pharmacology
- No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
- (2017) Patrick Vizeli et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
- (2017) Patrick Vizeli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Psychedelic Drugs in Biomedicine
- (2017) Evan J. Kyzar et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- OCT1 mediates hepatic uptake of sumatriptan and loss-of-functionOCT1polymorphisms affect sumatriptan pharmacokinetics
- (2016) J Matthaei et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- (2016) Anna Rickli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy
- (2016) Timothy Amoroso et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption
- (2016) Ulrike M. Stamer et al. PAIN
- CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals
- (2016) Yasmin Schmid et al. Pharmacogenetics and Genomics
- Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
- (2015) Anna Rickli et al. NEUROPHARMACOLOGY
- Role of organic cation transporters (OCTs) in the brain
- (2015) Thomas Couroussé et al. PHARMACOLOGY & THERAPEUTICS
- Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1
- (2015) Tina Seitz et al. Genome Medicine
- A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
- (2014) Alok Sharma et al. ANNALS OF PHARMACOTHERAPY
- ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children
- (2014) Raja Venkatasubramanian et al. PHARMACOGENOMICS
- Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration
- (2013) Mladen V. Tzvetkov et al. BIOCHEMICAL PHARMACOLOGY
- Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats
- (2013) Charles W Schindler et al. BRITISH JOURNAL OF PHARMACOLOGY
- Precise comparison of protein localization among OCT, OAT, and MATE in human kidney
- (2013) Hideyuki Motohashi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
- (2013) L.D. Simmler et al. NEUROPHARMACOLOGY
- The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1
- (2012) Ali R. Saadatmand et al. BIOCHEMICAL PHARMACOLOGY
- Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
- (2012) Michael C Mithoefer et al. JOURNAL OF PSYCHOPHARMACOLOGY
- MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
- (2012) Rafael de la Torre et al. Frontiers in Genetics
- VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse
- (2011) Lee E. Eiden et al. Annals of the New York Academy of Sciences
- Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia
- (2011) Shad B. Smith et al. ARTHRITIS AND RHEUMATISM
- Genetically Polymorphic OCT1: Another Piece in the Puzzle of the Variable Pharmacokinetics and Pharmacodynamics of the Opioidergic Drug Tramadol
- (2011) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response
- (2011) A Bacq et al. MOLECULAR PSYCHIATRY
- Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene
- (2010) Pieter J. Hoekstra et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) (“San Pedro”) and their relevance to shamanic practice
- (2010) Olabode Ogunbodede et al. JOURNAL OF ETHNOPHARMACOLOGY
- Interaction of organic cation transporter 3 (SLC22A3) and amphetamine
- (2010) Hao-Jie Zhu et al. JOURNAL OF NEUROCHEMISTRY
- The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity
- (2010) Gregory M. Miller JOURNAL OF NEUROCHEMISTRY
- The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
- (2010) Michael C Mithoefer et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Functional Characterization of the Human Organic Cation Transporter 2 Variant p.270Ala>Ser
- (2009) O. Zolk et al. DRUG METABOLISM AND DISPOSITION
- Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver
- (2009) Anne T. Nies et al. HEPATOLOGY
- Predicting new molecular targets for known drugs
- (2009) Michael J. Keiser et al. NATURE
- Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice
- (2008) Vincent Vialou et al. JOURNAL OF NEUROCHEMISTRY
- Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis
- (2007) A Kling et al. ANNALS OF THE RHEUMATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search